全基因组关联分析首次识别阿尔茨海默病精神病性症状的风险位点
该研究对12,317例阿尔茨海默病(AD)受试者(其中5445例伴精神病性症状,AD+P)进行全基因组荟萃分析,发现ENPP6和SUMF1两个位点与AD+P全基因组显著关联,并揭示AD+P与认知/教育程度负遗传相关、与抑郁症状正遗传相关,多基因风险评分支持其与双相障碍及AD风险的遗传重叠。
要点
- ENPP6 rs9994623(OR 1.16)和SUMF1 rs201109606(OR 0.65)与AD+P全基因组显著关联。
- AD+P与认知及教育程度呈负遗传相关,与抑郁症状呈正遗传相关。
- 多基因风险评分支持AD+P与双相障碍及AD风险的遗传重叠,独立于ε4效应。
核心结论
- 首次无偏识别AD中精神病性症状与常见遗传变异的关联,揭示其遗传架构。
研究设计与样本
- 对12,317例AD受试者(其中5445例AD+P)进行全基因组荟萃分析。
主要发现
- ENPP6位点rs9994623与AD+P关联OR(95%CI)1.16(1.10,1.22),p=1.26×10-8。
- SUMF1位点rs201109606与AD+P关联OR(95%CI)0.65(0.56-0.76),p=3.24×10-8。
- 基于基因分析因APOE风险单倍型ε4识别出APOE显著关联。
- AD+P与认知及教育程度呈负遗传相关,与抑郁症状呈正遗传相关。
- AD+P与双相障碍呈更强负遗传相关,多基因风险评分支持与AD风险变异正相关。
关键数值与推荐
- 全基因组显著阈值未在原文摘要中明确报告。
临床怎么用
- 提示AD+P具有可识别的常见遗传风险架构,支持未来开展遗传分层与机制研究。
局限性
- 原文摘要未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Psychotic symptoms, defined as the occurrence of delusions or hallucinations, are frequent in Alzheimer disease (AD with psychosis, AD + P). AD + P affects ~50% of individuals with AD, identifies a subgroup with poor outcomes, and is associated with a greater degree of cognitive impairment and depressive symptoms, compared to subjects without psychosis (AD - P). Although the estimated heritability of AD + P is 61%, genetic sources of risk are unknown. We report a genome-wide meta-analysis of 12,317 AD subjects, 5445 AD + P. Results showed common genetic variation accounted for a significant portion of heritability. Two loci, one in ENPP6 (rs9994623, O.R. (95%CI) 1.16 (1.10, 1.22), p = 1.26 × 10-8) and one spanning the 3'-UTR of an alternatively spliced transcript of SUMF1 (rs201109606, O.R. 0.65 (0.56-0.76), p = 3.24 × 10-8), had genome-wide significant associations with AD + P. Gene-based analysis identified a significant association with APOE, due to the APOE risk haplotype ε4. AD + P demonstrated negative genetic correlations with cognitive and educational attainment and positive genetic correlation with depressive symptoms. We previously observed a negative genetic correlation with schizophrenia; instead, we now found a stronger negative correlation with the related phenotype of bipolar disorder. Analysis of polygenic risk scores supported this genetic correlation and documented a positive genetic correlation with risk variation for AD, beyond the effect of ε4. We also document a small set of SNPs likely to affect risk for AD + P and AD or schizophrenia. These findings provide the first unbiased identification of the association of psychosis in AD with common genetic variation and provide insights into its genetic architecture.
引用
- DeMichele-Sweet MAA, Klei L, Creese B, et al. Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease. Mol Psychiatry. 2021. PMID: 34112972. doi:10.1038/s41380-021-01152-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。